UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Can Risk Stratification Scores Improve Selection Of Patients Who Need Primary Prevention Implantable Cardioverter-Defibrillators Or Should We Just Follow The Rules?

The American journal of cardiology, 2024-01, Vol.211, p.355-357

Naccarelli, Gerald V

2024

Volltextzugriff (PDF)

Direct Oral Anticoagulants: Patients Benefit When Prescribers Get the Message

The American journal of cardiology, 2023-11, Vol.206, p.365-367

Naccarelli, Gerald V.

2023

Volltextzugriff (PDF)

Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

The American journal of cardiology, 2009-12, Vol.104 (11), p.1534-1539

2009

Volltextzugriff (PDF)

Direct Oral Anticoagulant Dosing: Truth or Consequences

Journal of the American College of Cardiology, 2020-09, Vol.76 (12), p.1437-1439

Naccarelli, Gerald V.

2020

Volltextzugriff (PDF)

Should Patients with Subclinical Atrial Fibrillation Receive Anticoagulation?

The American journal of medicine, 2024-05, Vol.137 (5), p.383-385

2024

Volltextzugriff (PDF)

Cardiac Contractility Modulation Therapy: Should We Be Aiming Higher for Patients With Moderately Severe Heart Failure?

Texas Heart Institute journal, 2022-11, Vol.49 (6)

2022

Volltextzugriff (PDF)

Controversies in Hypertension I: The Optimal Assessment of Blood Pressure Load and Implications for Treatment

The American journal of medicine, 2022-09, Vol.135 (9), p.1043-1050

2022

Volltextzugriff (PDF)

Controversies in Hypertension V: Resistant and Refractory Hypertension

The American journal of medicine, 2024-01, Vol.137 (1), p.12-22

2024

Volltextzugriff (PDF)

Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial

Europace (London, England), 2023-03, Vol.25 (3), p.845-854

2023

Volltextzugriff (PDF)

Antiarrhythmic Drug Therapy: Where Do We Go From Here?

Circulation (New York, N.Y.), 2024-03, Vol.149 (11), p.801-803

2024

Volltextzugriff (PDF)

Women and atrial fibrillation

Journal of cardiovascular electrophysiology, 2021-10, Vol.32 (10), p.2793-2807

2021

Volltextzugriff (PDF)

Relation of Obesity to New-Onset Atrial Fibrillation and Atrial Flutter in Adults

The American journal of cardiology, 2018-05, Vol.121 (9), p.1072-1075

2018

Volltextzugriff (PDF)

Re-Analyses of 8 Historical Trials in Cardiovascular Medicine Assessing Multimorbidity Burden and Its Association with Treatment Response

The American journal of medicine, 2024-07, Vol.137 (7), p.608-616.e3

2024

Volltextzugriff (PDF)

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-04, Vol.321 (13), p.1261

2019

Volltextzugriff (PDF)

Are Class IC Antiarrhythmic Agents Safe in Atrial Fibrillation Patients With Nonobstructive Coronary Artery Disease?

JACC. Clinical electrophysiology, 2023-07, Vol.9 (7), p.1181-1183

Naccarelli, Gerald V.

2023

Volltextzugriff (PDF)

Aggressive treatment of atrial fibrillation in hypertrophic cardiomyopathy patients improve quality of life

Journal of cardiovascular electrophysiology, 2024-04, Vol.35 (4), p.664-666

2024

Volltextzugriff (PDF)

The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2022-05, Vol.79 (19), p.1932-1948

2022

Volltextzugriff (PDF)

Practical Management Guide for Clinicians Who Treat Patients with Amiodarone

The American journal of medicine, 2016-05, Vol.129 (5), p.468-475

2016

Volltextzugriff (PDF)

A systematic review, meta-analysis, and meta regression of the sham controlled renal denervation randomized controlled trials

Trends in cardiovascular medicine, 2023-11, Vol.33 (8), p.490-498

2023

Volltextzugriff (PDF)

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

European heart journal, 2015-07, Vol.36 (28), p.1805-1811

2015

Volltextzugriff (PDF)

Understanding Antiarrhythmic Drug Efficacy for the Clinical Practitioner: There Is More than Meets the Eye

The American journal of medicine, 2022-07, Vol.135 (7), p.822-827

2022

Volltextzugriff (PDF)

Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?

Journal of cardiovascular electrophysiology, 2023-02, Vol.34 (2), p.453-454

2023

Volltextzugriff (PDF)

Controversies in Hypertension IV: Renal Denervation

The American journal of medicine, 2023-09, Vol.136 (9), p.857-868

2023

Volltextzugriff (PDF)

Assessment of Comorbidity Burden and Treatment Response: Reanalysis of the SCD-HEFT Trial

Drugs & aging, 2022-02, Vol.39 (2), p.165-173

2022

Volltextzugriff (PDF)

Do Mineralocorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?

Journal of the American College of Cardiology, 2021-07, Vol.78 (2), p.153-155

2021

Volltextzugriff (PDF)

1 – 25 von 460

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(369)
Mit Volltextzugriff
(406)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(291)
Life Sciences & Biomedicine
(290)
Cardiovascular System & Cardiology
(250)
Cardiac & Cardiovascular Systems
(247)
Humans
(208)
Atrial Fibrillation
(90)
Female
(87)
Male
(85)
Anti-Arrhythmia Agents - Therapeutic Use
(67)
Cardiac Arrhythmia
(63)
Aged
(60)
Middle Aged
(57)
Atrial Fibrillation - Drug Therapy
(53)
Treatment Outcome
(53)
Cardiology
(47)
Biological And Medical Sciences
(45)
Medical Sciences
(44)
Electrocardiography
(42)
Heart
(36)
Stroke
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Can Risk Stratification Scores Improve Selection Of Patients Who Need Primary Prevention Implantable Cardioverter-Defibrillators Or Should We Just Follow The Rules?

Direct Oral Anticoagulants: Patients Benefit When Prescribers Get the Message

Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

Direct Oral Anticoagulant Dosing: Truth or Consequences

Should Patients with Subclinical Atrial Fibrillation Receive Anticoagulation?

Cardiac Contractility Modulation Therapy: Should We Be Aiming Higher for Patients With Moderately Severe Heart Failure?

Controversies in Hypertension I: The Optimal Assessment of Blood Pressure Load and Implications for Treatment

Controversies in Hypertension V: Resistant and Refractory Hypertension

Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial

Antiarrhythmic Drug Therapy: Where Do We Go From Here?

Women and atrial fibrillation

Relation of Obesity to New-Onset Atrial Fibrillation and Atrial Flutter in Adults

Re-Analyses of 8 Historical Trials in Cardiovascular Medicine Assessing Multimorbidity Burden and Its Association with Treatment Response

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

Are Class IC Antiarrhythmic Agents Safe in Atrial Fibrillation Patients With Nonobstructive Coronary Artery Disease?

Aggressive treatment of atrial fibrillation in hypertrophic cardiomyopathy patients improve quality of life

The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review

Practical Management Guide for Clinicians Who Treat Patients with Amiodarone

A systematic review, meta-analysis, and meta regression of the sham controlled renal denervation randomized controlled trials

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

Understanding Antiarrhythmic Drug Efficacy for the Clinical Practitioner: There Is More than Meets the Eye

Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?

Controversies in Hypertension IV: Renal Denervation

Assessment of Comorbidity Burden and Treatment Response: Reanalysis of the SCD-HEFT Trial

Do Mineralocorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?

Suchergebnisse filtern